SEC EDGAR · Financial report
ZBH: 10-Q financial filing
Filed 10-Q for an event or period dated 2026-06-30. Read the company report for its disclosures.
Follow ZBH- Became public
- Aug 5, 2026, 4:06 PM EDT
- Event / period date
- Jun 30, 2026
- Collected
- Nov 9, 2026, 12:07 PM EST
Why this is connected
This filing identifies ZIMMER BIOMET HOLDINGS, INC. as the issuer of the security. The company's SEC identifier connects it to ZBH.
Source evidence
Read the source excerpt or record
10-Q ` UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED June 30, 2026 Commission File Number 001-16407 ZIMMER BIOMET HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 13-4151777 (State or other jurisdiction of incorporation or organization) (IRS Employer Identification No.) 345 East Main Street , Warsaw , IN 46580 (Address of principal executive offices) Telephone: ( 574 ) 373-3333 Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.01 par value ZBH New York Stock Exchange 2.425% Notes due 2026 ZBH 26 New York Stock Exchange 1.164% Notes due 2027 ZBH 27 New York Stock Exchange 3.518% Notes due 2032 ZBH 32 New York Stock Exchange Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definition
Price change after we could observe it
+0.14% ZBH
Adjusted closing prices from Nov 10, 2026 to Nov 11, 2026. SPY changed 1.32% over the same dates. The start is the first available close after both publication and collection. This is a price comparison, not an executed trade, investor profit, or a backtested strategy.
Congressional trading in ZBH
These disclosures provide context. Their presence does not establish a link between a trader and the event.
- Nov 5, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
Sold Zimmer Biomet Holdings ZBH
$1K–$15K · Traded Oct 30, 2026 · disclosed Nov 5, 2026 · Spouse
Traded 5 days before earnings - Nov 5, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
Sold Zimmer Biomet Holdings ZBH
$1K–$15K · Traded Oct 30, 2026 · disclosed Nov 5, 2026 · Dependent
Traded 5 days before earnings - Nov 5, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
Sold Zimmer Biomet Holdings ZBH
$1K–$15K · Traded Oct 5, 2026 · disclosed Nov 5, 2026 · Spouse
- Oct 7, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
Sold Zimmer Biomet Holdings ZBH
$1K–$15K · Traded Sep 14, 2026 · disclosed Oct 7, 2026 · Spouse
- Oct 7, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
Sold Zimmer Biomet Holdings ZBH
$1K–$15K · Traded Sep 14, 2026 · disclosed Oct 7, 2026 · Dependent
- Oct 7, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
Sold Zimmer Biomet Holdings ZBH
$1K–$15K · Traded Sep 11, 2026 · disclosed Oct 7, 2026 · Spouse
- Oct 7, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
Bought Zimmer Biomet Holdings ZBH
$1K–$15K · Traded Sep 11, 2026 · disclosed Oct 7, 2026 · Dependent
- Jul 21, 2026$1K–$15K
Sen. Alan Armstrong (R-OK)
Bought Zimmer Biomet Holdings ZBH
$1K–$15K · Traded Mar 27, 2026 · disclosed Jul 21, 2026 · filed 116 days later
Committee overlap: HELP
Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.